About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron
UTime (NASDAQ: WTO) has announced its collaboration on Circul VS, a continuous blood pressure measurement technology system developed with Dr. Ehud Baron. The system includes a BPwatch, Ring, and Smart Cradle, integrated into a cloud-based network. Circul VS utilizes ultrasound sensing technology and intelligent algorithms to provide real-time blood pressure waveform data with high accuracy.
The system has undergone clinical trials in partner hospitals, receiving positive feedback for its performance in non-invasive monitoring. Circul VS is designed for various applications, including hypertension screening, long-term management, and acute monitoring in hospital settings. UTime and Dr. Baron plan to further refine the technology for use in ICUs and other medical environments.
UTime (NASDAQ: WTO) ha annunciato la sua collaborazione su Circul VS, un sistema tecnologico per la misurazione continua della pressione sanguigna sviluppato con il Dr. Ehud Baron. Il sistema include un BPwatch, un anello e un cradle intelligente, integrati in una rete basata su cloud. Circul VS utilizza tecnologia di rilevamento ad ultrasuoni e algoritmi intelligenti per fornire dati in tempo reale sulle waveforms della pressione sanguigna con alta precisione.
Il sistema ha subito prove cliniche presso ospedali partner, ricevendo feedback positivi per le sue prestazioni nel monitoraggio non invasivo. Circul VS è progettato per varie applicazioni, tra cui screening per l'ipertensione, gestione a lungo termine e monitoraggio acuto in contesti ospedalieri. UTime e il Dr. Baron intendono ulteriormente affinare la tecnologia per l'uso in unità di terapia intensiva e in altri ambienti medici.
UTime (NASDAQ: WTO) ha anunciado su colaboración en Circul VS, un sistema de tecnología para la medición continua de la presión arterial desarrollado con el Dr. Ehud Baron. El sistema incluye un BPwatch, anillo y cuna inteligente, integrados en una red basada en la nube. Circul VS utiliza tecnología de detección por ultrasonido y algoritmos inteligentes para proporcionar datos en tiempo real de la forma de onda de la presión arterial con alta precisión.
El sistema ha sido sometido a pruebas clínicas en hospitales socios, recibiendo comentarios positivos por su rendimiento en el monitoreo no invasivo. Circul VS está diseñado para diversas aplicaciones, incluyendo cribado de la hipertensión, gestión a largo plazo y monitoreo agudo en entornos hospitalarios. UTime y el Dr. Baron planean seguir perfeccionando la tecnología para su uso en UCI y otros entornos médicos.
UTime (NASDAQ: WTO)는 Dr. Ehud Baron과 함께 개발한 지속적인 혈압 측정 기술 시스템 Circul VS와의 협업을 발표했습니다. 이 시스템에는 클라우드 기반의 네트워크에 통합된 BPwatch, 링, 스마트 크래들이 포함되어 있습니다. Circul VS는 초음파 감지 기술과 지능형 알고리즘을 활용하여 실시간 혈압 웨이브폼 데이터를 높은 정확도로 제공합니다.
이 시스템은 파트너 병원에서 임상 시험을 거쳤으며 비침습적 모니터링에서의 성능에 대해 긍정적인 피드백을 받았습니다. Circul VS는 고혈압 검진, 장기 관리 및 급성 모니터링을 포함한 다양한 용도로 설계되었습니다. UTime과 Dr. Baron은 ICU 및 다른 의료 환경에서의 사용을 위해 기술을 더욱 다듬을 계획입니다.
UTime (NASDAQ: WTO) a annoncé sa collaboration sur Circul VS, un système technologique de mesure continue de la pression artérielle développé avec le Dr Ehud Baron. Le système comprend un BPwatch, une bague et un berceau intelligent intégrés dans un réseau basé sur le cloud. Circul VS utilise la technologie de détection par ultrasons et des algorithmes intelligents pour fournir des données en temps réel sur la forme d'onde de la pression artérielle avec une grande précision.
Le système a subi des essais cliniques dans des hôpitaux partenaires, recevant des retours positifs concernant ses performances dans la surveillance non invasive. Circul VS est conçu pour diverses applications, notamment le dépistage de l'hypertension, la gestion à long terme et la surveillance aiguë dans des environnements hospitaliers. UTime et le Dr Baron prévoient d'affiner davantage la technologie pour son utilisation dans les unités de soins intensifs et d'autres environnements médicaux.
UTime (NASDAQ: WTO) hat seine Zusammenarbeit an Circul VS, einem kontinuierlichen Blutdruckmesssystem, das gemeinsam mit Dr. Ehud Baron entwickelt wurde, bekannt gegeben. Das System umfasst ein BPwatch, einen Ring und eine Smart Cradle, die in ein cloud-basiertes Netzwerk integriert sind. Circul VS nutzt Ultraschallsensorik und intelligente Algorithmen, um Echtzeit-Blutdruck-Wellenformdaten mit hoher Genauigkeit bereitzustellen.
Das System hat klinische Tests in Partnerkrankenhäusern durchlaufen und erhielt positives Feedback zu seiner Leistung im nicht-invasiven Monitoring. Circul VS ist für verschiedene Anwendungen konzipiert, darunter Hypertoniescreening, Langzeitmanagement und akute Überwachung in Krankenhausumgebungen. UTime und Dr. Baron planen, die Technologie weiter zu verfeinern, um sie in Intensivstationen und anderen medizinischen Umgebungen zu nutzen.
- Development of innovative continuous blood pressure monitoring system
- Utilization of advanced ultrasound sensing technology and intelligent algorithms
- Positive feedback from clinical trials in partner hospitals
- Versatility in application scenarios (screening, management, and acute monitoring)
- Potential for widespread use in ICUs and other medical settings
- None.
Insights
UTime's collaboration on Circul VS represents a significant leap in continuous blood pressure monitoring technology. The system's focus on capturing rapid fluctuations in blood pressure, often overlooked by competitors, could provide a more comprehensive view of cardiovascular health. The use of ultrasound sensing technology and intelligent algorithms for real-time data collection is particularly noteworthy.
However, while the technology seems promising, investors should note that UTime is primarily known for mobile devices, not medical technology. This diversification into healthcare tech represents a significant pivot that may require substantial investment and regulatory navigation. The success of Circul VS will largely depend on its clinical adoption and regulatory approvals, which are not yet confirmed. Despite positive feedback from trials, the path to widespread use in ICUs and other medical settings could be long and challenging.
The continuous blood pressure monitoring market is growing rapidly, driven by increasing prevalence of hypertension and cardiovascular diseases. UTime's entry with Circul VS could potentially disrupt this space, especially given its claimed accuracy approaching invasive techniques. The system's adaptability to various clinical scenarios - from screening to acute monitoring - expands its potential market reach.
However, UTime faces stiff competition from established medical device companies. Its success will hinge on pricing strategy, distribution channels and ability to build trust among healthcare providers. The partnership with Dr. Ehud Baron lends credibility, but UTime's lack of track record in medical devices may pose challenges. Investors should closely monitor initial adoption rates and any regulatory milestones. While the potential is significant, execution risks remain high for a company transitioning from mobile devices to advanced medical technology.
Circul VS features the BPwatch, Ring, and Smart Cradle, integrated into a sophisticated cloud-based network and service system. Unlike other systems on the market, Circul VS focuses on capturing rapid blood pressure fluctuations caused by changes in endothelial function and vascular tone—critical factors often neglected by competitors.
Utilizing state-of-the-art ultrasound sensing technology and intelligent algorithms, Circul VS provides continuous, real-time blood pressure waveform data with exceptional accuracy. This innovative technology is the result of comprehensive market research and extensive clinical studies.
As part of this strategic collaboration, UTime has harnessed expertise in biomedical engineering and electronic technology to ensure the Circul VS system is not only precise but also stable and reliable in diverse clinical settings.
Having undergone clinical trials in multiple partner hospitals, Circul VS has garnered positive feedback for its outstanding performance in the non-invasive monitoring space, offering systolic and diastolic pressure readings with accuracy approaching that of invasive techniques.
During its development, Circul VS was tailored to meet the needs of different application scenarios—including hypertension screening for healthy individuals, long-term management for diagnosed hypertension patients, and acute monitoring for hospitalized patients. This adaptability ensures it meets the specific demands of various clinical environments.
The launch of Circul VS marks a pivotal advancement in blood pressure monitoring technology. Together with Dr. Ehud Baron, UTime plans to continue refining this technology, aiming to enhance its intelligence and accuracy for widespread use in ICUs and other medical settings, ultimately improving patient care and quality of life.
About UTime Limited
UTime Ltd., established in 2008, provides cost-effective mobile devices to consumers globally and to helping low-income individuals from established markets, including the United States and emerging markets such as India and other countries in South Asia and Africa have better access to updated mobile technology. Since 2024, UTime has been committed to transforming health and wellness through innovative medical wearable technologies. By leveraging cutting-edge research and strategic partnerships, UTime aims to provide effective solutions for disease prevention and health management on a global scale. For more information, visit the Company's website at http://www.utimeworld.com/.
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the ability of the Company to regain compliance with Nasdaq continued listing requirements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in the "Risk Factors" section of the Annual Report in Form 20-F filed with the SEC on July 30, 2024. Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
For more information, please contact:
Eaky Tan
eaky@westock.com
View original content:https://www.prnewswire.com/news-releases/about-circul-vs-a-core-continuous-blood-pressure-measurement-technology-system-developed-in-partnership-with-dr-ehud-baron-302230345.html
SOURCE UTime Limited
FAQ
What is Circul VS and how does it work?
What components make up the Circul VS system?
Has Circul VS undergone clinical trials?
What are the potential applications for Circul VS?
